- Home
- CLNN vs FMY Comparison
CLNN vs FMY Comparison
Compare CLNN & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- FMY
- Stock Information
- Founded
- CLNN 2012
- FMY 2005
- Country
- CLNN United States
- FMY United States
- Employees
- CLNN N/A
- FMY N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- FMY Finance/Investors Services
- Sector
- CLNN Health Care
- FMY Finance
- Exchange
- CLNN Nasdaq
- FMY Nasdaq
- Market Cap
- CLNN 57.9M
- FMY 50.5M
- IPO Year
- CLNN N/A
- FMY N/A
- Fundamental
- Price
- CLNN $6.17
- FMY $12.25
- Analyst Decision
- CLNN Strong Buy
- FMY
- Analyst Count
- CLNN 6
- FMY 0
- Target Price
- CLNN $32.67
- FMY N/A
- AVG Volume (30 Days)
- CLNN 117.0K
- FMY 10.1K
- Earning Date
- CLNN 11-12-2025
- FMY 01-01-0001
- Dividend Yield
- CLNN N/A
- FMY 6.98%
- EPS Growth
- CLNN N/A
- FMY N/A
- EPS
- CLNN N/A
- FMY N/A
- Revenue
- CLNN $286,000.00
- FMY N/A
- Revenue This Year
- CLNN N/A
- FMY N/A
- Revenue Next Year
- CLNN $2,178.18
- FMY N/A
- P/E Ratio
- CLNN N/A
- FMY N/A
- Revenue Growth
- CLNN N/A
- FMY N/A
- 52 Week Low
- CLNN $2.28
- FMY $10.71
- 52 Week High
- CLNN $7.10
- FMY $12.17
- Technical
- Relative Strength Index (RSI)
- CLNN 59.58
- FMY 48.65
- Support Level
- CLNN $5.77
- FMY $12.26
- Resistance Level
- CLNN $6.54
- FMY $12.37
- Average True Range (ATR)
- CLNN 0.57
- FMY 0.08
- MACD
- CLNN -0.04
- FMY -0.00
- Stochastic Oscillator
- CLNN 53.03
- FMY 39.13
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.